Eisai and Biogen Announces That The Therapeutic Goods Administration Of Australia Has Confirmed The Initial Decision To Decline The Approval Of Humanized Anti-Soluble Aggregated Amyloid-Beta Monoclonal Antibody Lecanemab As A Treatment For Early...
Pantech Global Bhd's Shares Down 29.41% From IPO Price
Cyclacel Pharmaceuticals Announces Leadership Change After $6.3M Share Purchase; Datuk Dr. Doris Wong Sing Ee Acquires 70% Stake And Becomes CEO; David Lazar Resigns As Interim CEO, Kiu Cu Seng Appointed CFO
Gladstone Investment Expands Capital Investment To Pyrotek Special Effects For Unique Pyrotechnic Acquisitions; Terms Not Disclosed
Rentia - Completion of Scope 3 calculations for six group companies.
Koyu Rentia <7081> announced on the 25th that it has begun calculating the Scope 3 results for the fiscal year 2023 regarding greenhouse gas (GHG) emissions across the entire supply chain of the six group companies. Scope 3 refers to the indirect GHG emissions throughout a company's value chain and is an important Indicator for understanding the overall environmental impact. The company group has been working on reducing environmental burdens, and the commencement of the Scope 3 calculation is part of this effort.
Stifel Maintains Buy on Comfort Systems USA, Lowers Price Target to $471